Supply Chain

FDA approves generic Tamiflu

The Food and Drug Administration approved Nesher Pharmaceuticals’ oseltamivir phosphate capsules, reports Business Standard.

By: Mackenzie Bean

Monday, February 27th, 2017

Here are three things to know.

1. The drug is an anti-viral used for the prevention and treatment of influenza virus infection.

2. The treatment represents a generic version of Genentech’s Tamiflu.

2. Nesher, a subsidiary of Zydus Phramaceuticals USA, will produce the drug at a manufacturing facility in St. Louis.

More articles on supply chain:

Sanofi, Lonza to build $285M biologics facility
4 statistics on 2017 pharma price hikes
Lupin CEO: Border tax would significantly disrupt generic drugmakers’ supply chains

Next Up in Supply Chain

Where healthcare tariffs stand now: 6 takeaways

Healthcare leaders are navigating the new era of trade policy following a series of tariffs recently imposed by President Donald…

By: Alexandra Murphy
Yesterday
Cold drug swabs recalled over fungal contamination risk

Church & Dwight Co. has issued a nationwide recall of several over-the-counter swab-based drug products due to the risk of…

By: Alexandra Murphy
2 days ago
70% of US medical devices are only available overseas, report finds

As hospital executives and healthcare organizations express concern about how tariffs may affect the medical supply chain, a recent industry…

By: Paige Twenter
2 days ago

Comments are closed.